Clinical Manifestations of Sarin Nerve Gas Exposure

JAMA

Volumn 290, Issue 5, 2003, Pages 659-662

  Lee, Ernest C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; DIAZEPAM; NERVE GAS; PRALIDOXIME CHLORIDE; SARIN; TROPICAMIDE; CHEMICAL WARFARE AGENT; CHOLINESTERASE INHIBITOR;

ACUTE TOXICITY; CHEMICAL WARFARE; CLINICAL FEATURE; ENVIRONMENTAL EXPOSURE; EPIGASTRIC PAIN; HEADACHE; HEART VENTRICLE FIBRILLATION; HUMAN; HYPERTENSION; INTOXICATION; NAUSEA; PRIORITY JOURNAL; REVIEW; SYMPTOMATOLOGY; TOXICOKINETICS; TREATMENT INDICATION; VISUAL IMPAIRMENT; VOMITING; HISTORY; JAPAN; TERRORISM;

CHEMICAL WARFARE AGENTS; CHOLINESTERASE INHIBITORS; ENVIRONMENTAL EXPOSURE; HISTORY, 20TH CENTURY; HUMANS; JAPAN; POISONING; SARIN; TERRORISM;

EID: 0042709619     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.290.5.659     Document Type: Review

References (28)

1. Urbanetti JS. Toxic inhalation injury. In: Zajtchuk R, Bellamy RF, eds. Medical Aspects of Chemical and Biological Warfare. Washington, DC: Office of the Surgeon General, US Dept of the Army; 1997:247-270.
2. Medical Management of Chemical Casualties Handbook. 3rd ed. Aberdeen Proving Ground, Md: USAMRICO; 2000.
3. Okudera H, Morita H, Iwashita T, et al. Unexpected nerve gas exposure in the city of Matsumoto: report of rescue activity in the first sarin gas terrorism. Am J Emerg Med. 1997;15:527-528.
4. Okumura T, Suzuki K, Fukuda A, et al. The Tokyo subway sarin attack: disaster management, part 2: hospital response. Acad Emerg Med. 1998;5:618-624.
5. Yokoyama K, Arak S, Murata K, et al. A preliminary study on delayed vestibulo-cerebellar effects of Tokyo Subway sarin poisoning in relation to gender difference: frequency analysis of postural sway. J Occup Environ Med. 1998;40:17-21.
6. Stewart CE, Sullivan J Jr. Military munitions and antipersonnel agents. In: Sullivan JB Jr, Krieger G, eds. Hazardous Materials Toxicology: Clinical Principles of Environmental Health. Baltimore, Md: Williams & Wilkins; 1992.
7. Somani SM, Jaax NK, Graham JS, Mcleod CG Jr. Cardiomyopathy in soman and sarin intoxicated rates. Toxicol Lett. 1987;36:243-249.
8. Brown MA, Brix KA. Review of health consequences from high-, intermediate-, and low-level exposure to organophosphorous nerve agents. J App Toxicol. 1998;18:393-408.
9. Agency for Toxic Substances and Disease Registry. Medical management guidelines for nerve agents tabun (GA); sarin (GB); soman (GD); and VX. Available at: http://www.atsdr.cdc.gov/MHMI/mmg166 .html. Accessibility verified May 30, 2003.
10. Somani SM. Chemical Warfare Agents. New York, NY: Academic Press; 1992.
11. Spencer P, Wilson B, Albuquerque E. Sarin, other "nerve agents," and their antidotes. In: Spencer P, Schaumburg H, Ludolph A, eds. Experimental and Clinical Neurotoxicology. 2nd ed. New York, NY: Oxford University Press; 2000.
12. Tripathi HL, Dewey WL. Comparison of the effects of diisopropylfluorophosphate, sarin, soman, and tabun on toxicity and brain acetylcholinesterase activity in mice. J Toxicol Environ Health. 1989;26:437-446.
13. Gray AP. Design and structure-activity relationships of antidotes to organophosphorus anticholinesterase agents. Drug Metab Rev. 1984;15:557-589.
14. Sidell FL, Borak J. Chemical warfare agents, II: nerve agents. Ann Emerg Med. 1992;21:865-871.
15. Devereaux A, Amundson DE, Parrish JS, Lazarus AA. Vesicants and nerve agents in chemical warfare. Postgrad Med. 2002;112:90-96.
16. Fulco CE, Liverman CT, Sox HC. Gulf War and Health. Vol 1. Washington, DC: National Academy Press; 2000.
17. Rocha ES, Chebabo Sr, Santos MD, Aracava Y, Albuquerque EX. An analysis of low-level doses of cholinesterase inhibitors in cultured neurons and hippocampal slices of rates. Drug Chem Toxicol. 1998;21:191-200.
18. Chebabo SR, Santos MD, Albuquerque EX. The organophosphate sarin, at low concentrations, inhibits the evoked release of GABA in rat hyppocampal slices. Neurotoxicology. 1999;20:871-882.
19. eMedicine: Instant Access to the Minds of Medicine. CBRNE-Nerve Agents, G-series: Tabun, Sarin, Soman. Available at: http://www.emedicine.com/emerg/topic898.htm. Accessibility verified June 1, 2003.
20. Department of Defense. Army Medical NBC Battlebook. Mount, Laurel, NJ: Progressive Management; 2001.
21. Lotti M. Organophosphorous compounds. In: Spencer P, Schaumburg H, Ludolph A, eds. Experimental and Clinical Neurotoxicology. 2nd ed. New York, NY: Oxford University Press; 2000.
22. Gunderson CH, Lehmann Dr, Sidell Fr, Jabbari B. Nerve agents: a review. Neurology. 1992;42:946-950.
23. Nozaki H, Hori S, Shinozawa Y, et al. Relationship between pupil size and acetylcholinesterase activity in patients exposed to sarin vapor. Intensive Care Med. 1997;23:1005-1007.
24. Holstege CP, Kirk M, Sidell FR. Chemical warfare: nerve agent poisoning. Crit Care Clin. 1997;13: 923-942.
25. Prevention and treatment of injury from chemical warfare agents. Med Lett Drugs Ther. 2002;44: 1-4.
26. Woodall J. Tokyo subway gas attack. Lancet. 1997; 350:296.
27. Sidell F. Proceedings of seminar responding to the consequences of chemical and biological terrorism. Washington, DC: Government Printing Office; 1995: 232-233. USPHS/OEP.
28. Okumura T, Suzuki K, Fukuda A, et al. The Tokyo subway sarin attack: disaster management, part 3: national and international responses. Academic Emergency Medicine. 1998;5:625-628.